Photo by freestocks on Unsplash
Dr. Roger Pomerantz, Chairman and CEO of ContraFect Corp. CFRX, was a guest speaker at Benzinga’s Global Small Cap Conference in December 2021.
Dr. Roger discussed the company’s biological therapies for life-threatening, drug-resistant infectious diseases. He also addresses ContraFect’s innovations at a time when many treatments for infectious diseases are of limited effectiveness.
Watch the full interview here:
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
